Activation of Vγ9Vδ2 T cells by NKG2D

被引:252
作者
Rincon-Orozco, B
Kunzmann, V
Wrobel, P
Kabelitz, D
Steinle, A
Herrmann, T
机构
[1] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany
[2] Univ Wurzburg, Med Poliklin, D-97078 Wurzburg, Germany
[3] Univ Klinikum Schleswig Holstein, Inst Immunol, Kiel, Germany
[4] Univ Tubingen, Inst Zellbiol, Tubingen, Germany
关键词
D O I
10.4049/jimmunol.175.4.2144
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human V gamma 9V delta 2 T cells recognize phosphorylated nonpeptide Ags (so called phosphoantigens), certain tumor cells, and cells treated with aminobisphosphonates. NKG2D), an activating receptor for NK cells, has been described as a potent costimulatory receptor in the Ag-specific activation of gamma delta and CD8 T cells. This study provides evidence that V gamma 9V delta 2 T cells may also be directly activated by NKG2D. Culture of PBMC with immobilized NKG2D-specific mAb or NKG2D ligand MHC class I related protein A (MICA) induces the up-regulation of CD69 and CD25 in NK and V gamma 9V delta 2 but not in CD8 T cells. Furthermore, NKG2D triggers the production of TNF-alpha but not of IFN-gamma, as well as the release of cytolytic granules by V gamma 9V delta 2 T cells. Purified V gamma 9V delta 2 T cells kill MICA-transfected RMA mouse cells but not control cells. Finally, DAP10, which mediates NKG2D signaling in human NK cells, was detected in resting and activated V gamma 9V delta 2 T cells. These remarkable similarities in NKG2D function in NK and V gamma 9V delta 2 T cells may open new perspectives for V gamma 9V delta 2 T cell-based immunotherapy, e.g., by Ag-independent killing of NKG2D ligand-expressing tumors.
引用
收藏
页码:2144 / 2151
页数:8
相关论文
共 54 条
[1]   Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors [J].
André, P ;
Castriconi, R ;
Espéli, M ;
Anfossi, N ;
Juarez, T ;
Hue, S ;
Conway, H ;
Romagné, F ;
Dondero, A ;
Nanni, M ;
Caillat-Zucman, S ;
Raulet, DH ;
Bottino, C ;
Vivier, E ;
Moretta, A ;
Paul, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) :961-971
[2]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[3]   A chemical basis for selective recognition of nonpeptide antigens by human δ T cells [J].
Belmant, C ;
Espinosa, E ;
Halary, F ;
Tang, Y ;
Peyrat, MA ;
Sicard, H ;
Kozikowski, A ;
Buelow, R ;
Poupot, R ;
Bonneville, M ;
Fournié, JJ .
FASEB JOURNAL, 2000, 14 (12) :1669-1670
[4]   NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway [J].
Billadeau, DD ;
Upshaw, JL ;
Schoon, RA ;
Dick, CJ ;
Leibson, PJ .
NATURE IMMUNOLOGY, 2003, 4 (06) :557-564
[5]  
Boullier S, 1999, EUR J IMMUNOL, V29, P90
[6]  
BUKOWSKI JF, 1995, J IMMUNOL, V154, P998
[7]   Time-varying risk and return in the bond market: A test of a new equilibrium pricing model [J].
Campbell, CJ ;
Kazemi, HB ;
Nanisetty, P .
REVIEW OF FINANCIAL STUDIES, 1999, 12 (03) :631-642
[8]   Vγ2Vδ2+ T cells and anti-microbial immune responses [J].
Chen, ZW ;
Letvin, NL .
MICROBES AND INFECTION, 2003, 5 (06) :491-498
[9]   Ovarian carcinoma expresses the NKG2D ligand letal and promotes the survival and expansion of CD28- antitumor T cells [J].
Conejo-Garcia, JR ;
Benencia, F ;
Courreges, MC ;
Gimotty, PA ;
Khang, E ;
Buckanovich, RJ ;
Frauwirth, KA ;
Zhang, L ;
Katsaros, D ;
Thompson, CB ;
Levine, B ;
Coukos, G .
CANCER RESEARCH, 2004, 64 (06) :2175-2182
[10]   MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function [J].
Das, H ;
Groh, V ;
Kuijl, C ;
Sugita, M ;
Morita, CT ;
Spies, T ;
Bukowski, JF .
IMMUNITY, 2001, 15 (01) :83-93